admin

New Job Opportunity – Senior Validation Scientist/Engineer

Careers Senior Validation Scientist/Engineer Location : Nottingham UK | Type : Full time, permanent Upperton Pharma Solutions is a Nottingham-based CDMO that specialises in the development and manufacture of pharmaceutical products, providing a complete service from early-stage feasibility to GMP clinical manufacture. Formulations cover a range of delivery routes, typically including oral (tablets & capsules), …

New Job Opportunity – Senior Validation Scientist/Engineer Read More »

New Job Opportunity – Quality Control Scientist Level I & ll (Hiring Multiple Candidates)

Careers Quality Control Scientist Level I & ll Location : Nottingham UK | Type : Full time, permanent (Hiring Multiple Candidates) Upperton Pharma Solutions is a Nottingham-based CDMO that specialises in the formulation and spray drying of pharmaceutical and biotechnology products, providing a complete service from early-stage feasibility through to development and scale-up (including GMP …

New Job Opportunity – Quality Control Scientist Level I & ll (Hiring Multiple Candidates) Read More »

New Job Opportunity – Business Development Director

Careers Business Development Director Location : Nottingham UK | Type : Full time, permanent Upperton Pharma Solutions is a Nottingham-based CDMO that specialises in the development and manufacture of pharmaceutical products, providing a complete service from early-stage feasibility to GMP clinical manufacture. Formulations cover a range of non-sterile delivery routes, typically including oral (tablets & …

New Job Opportunity – Business Development Director Read More »

New Job Opportunity – Formulation Development Scientist

Careers Formulation Development Scientist Location : Nottingham UK | Type : Full time, permanent Upperton Pharma Solutions is a Nottingham-based CDMO that specialises in the development and manufacturing of pharmaceutical products, providing a complete service from early-stage feasibility through to GMP clinical manufacture. Formulations cover a range of delivery routes, typically including oral (tablets & …

New Job Opportunity – Formulation Development Scientist Read More »

21st April 2022 – Inflexion announces investment into Upperton

Press Release 21st April 2022 – Inflexion announces investment into Upperton Inflexion is pleased to announce it has made a substantial investment into Upperton Pharma Solutions (“Upperton”), a UK-based specialist contract development and manufacturing organisation (“CDMO”) which has expertise in particle engineering for the pharmaceutical industry. Inflexion has invested alongside the founder and the management …

21st April 2022 – Inflexion announces investment into Upperton Read More »

5th April 2022 – Upperton Pharma Solutions launches nasal delivery development platform

Press Release 5th April 2022 – Upperton Pharma Solutions launches nasal delivery development platform Nottingham-based contract development and manufacturing organisation (CDMO), Upperton Pharma Solutions, has launched a unique nasal delivery development platform, UpperNose™, to make it easier and faster for small and mid-sized innovators to access the knowledge and capabilities necessary for the successful development …

5th April 2022 – Upperton Pharma Solutions launches nasal delivery development platform Read More »

Newsletter – February 24th 2022

24 February 2022 Newsletter Growing Interest in Nasal Delivery Recent trends have seen growing interest in exploiting nasal delivery as a means of delivering a wide range of drugs including small molecules and larger biologics for a wide range of indications. The nasal cavity is already a well-established delivery route capable of achieving rapid and …

Newsletter – February 24th 2022 Read More »

Newsletter – January 27th 2022

27 January 2022 Newsletter Upperton Adds New Nasal and Oral Delivery Technologies Upperton is pleased to announce that it has bolstered its nasal and oral delivery capabilities with the addition of a number of new analytical and formulation technologies. Nasal Delivery News – Upperton enhances its analytical capabilities by acquiring next generation nasal particle impaction technology …

Newsletter – January 27th 2022 Read More »

20th May 2021 – Upperton Nasal Delivery Article Published in ONdrugDelivery

Article 20th May 2021 – Upperton Nasal Delivery Article Published in ONdrugDelivery Formulation Options In Nasal Drug Delivery Upperton had an article published in Edition 119 ONdrugDeliver in May 2021 In the article Richard Johnson, CEO and founder of Upperton,  discusses the advantages of nasal delivery and why there is growing interest in this route …

20th May 2021 – Upperton Nasal Delivery Article Published in ONdrugDelivery Read More »

Scroll to Top